rs137852419
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PM1PM2PM5PP3_StrongPP5_Very_Strong
The NM_000132.4(F8):c.1660A>G(p.Ser554Gly) variant causes a missense change. The variant allele was found at a frequency of 0.000000912 in 1,096,238 control chromosomes in the GnomAD database, with no homozygous occurrence. There are no hemizygote samples in GnomAD. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. S554C) has been classified as Likely pathogenic.
Frequency
Consequence
NM_000132.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
F8 | NM_000132.4 | c.1660A>G | p.Ser554Gly | missense_variant | 11/26 | ENST00000360256.9 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
F8 | ENST00000360256.9 | c.1660A>G | p.Ser554Gly | missense_variant | 11/26 | 1 | NM_000132.4 | P1 | |
F8 | ENST00000647125.1 | c.*1536A>G | 3_prime_UTR_variant, NMD_transcript_variant | 12/14 |
Frequencies
GnomAD3 genomes ? Cov.: 22
GnomAD3 exomes AF: 0.00000545 AC: 1AN: 183446Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 67892
GnomAD4 exome AF: 9.12e-7 AC: 1AN: 1096238Hom.: 0 Cov.: 30 AF XY: 0.00 AC XY: 0AN XY: 361630
GnomAD4 genome ? Cov.: 22
ClinVar
Submissions by phenotype
not provided Pathogenic:3
Likely pathogenic, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Jan 17, 2017 | - - |
Likely pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Jun 20, 2022 | In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 23711294, 11858487, 19473423, 31361374, 7728145, 1301932) - |
Pathogenic, criteria provided, single submitter | clinical testing | ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories | Nov 28, 2023 | The F8 c.1660A>G; p.Ser554Gly variant (rs137852419), also known as Ser535Gly for legacy nomenclature, is reported in multiple individuals with mild hemophilia A (FVIII:C: 3-15 percent) (Diamond 1992, Antonarakis 1995, Liu 2002, Factor VIII database). This variant is also reported in ClinVar (Variation ID: 10226). It is only observed on one allele in the Genome Aggregation Database (v2.1.1), indicating it is not a common polymorphism. Computational analyses predict that this variant is deleterious (REVEL: 0.938). Based on available information, this variant is considered to be pathogenic. References: Factor VIII database link: http://www.factorviii-db.org/newstructure.php?aa_first=Ser&mut_id=607&aa_last=Gly Antonarakis SE et al. Molecular etiology of factor VIII deficiency in hemophilia A. Hum Mutat. 1995;5(1):1-22. PMID: 8851012. Diamond C et al. Amino acid substitutions in conserved domains of factor VIII and related proteins: study of patients with mild and moderately severe hemophilia A. Hum Mutat. 1992;1(3):248-57. PMID: 1301932. Liu ML et al. Non-inversion factor VIII mutations in 80 hemophilia A families including 24 with alloimmune responses. Thromb Haemost. 2002 Feb;87(2):273-6. PMID: 11858487. - |
Hereditary factor VIII deficiency disease Pathogenic:3
Pathogenic, reviewed by expert panel | curation | ClinGen Coagulation Factor Deficiency Variant Curation Expert Panel, Clingen | Feb 02, 2024 | The c.1660A>G (p.Ser554Gly) missense variant has a REVEL score of 0.938 which meets PP3 criteria (threshold >0.6). This variant is present in 1 hemizygote in gnomAD v2.1.1 and therefore, does not meet criteria for rarity in the population. Fifty-three patients are reported in Johnsen, et. al. 2107 with mild/moderate hemophilia A and the Gly554Ser variant, meeting F8 phenotype criteria for PS4_Very strong and PP4_Moderate (PMID: 29296726). The variant has been found to segregate with hemophilia A across 6 meioses among 4 different families, the PP1 criteria at the strong weight (Internal VCEP contributor). This variant has been reported in individuals who developed an inhibitor to factor replacement therapy and discrepant chromogenic and one-stage factor VIII activity levels (CDC CHAMPS database/Internal VCEP contributor). In summary, this variant meets criteria to be classified as pathogenic. ACMG/AMP criteria applied, as specified by the Coagulation Factor Deficiency Variant Curation Expert Panel for F8: PS4_Very strong, PP1_Strong, PP4_Moderate, PP3. - |
Pathogenic, no assertion criteria provided | literature only | OMIM | Jan 01, 1995 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Aug 08, 2023 | Variant summary: F8 c.1660A>G (p.Ser554Gly) results in a non-conservative amino acid change located in the multicopper oxidase-like, N-terminal domain (IPR011707) of the encoded protein sequence. Five of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 5.5e-06 in 183446 control chromosomes (gnomAD). c.1660A>G (also known as Ser535Gly) has been reported in the literature in multiple individuals affected with mild Factor VIII Deficiency (Hemophilia A) (examples: Diamond_1992 and Miller_2012). These data indicate that the variant is very likely to be associated with disease. The following publications have been ascertained in the context of this evaluation (PMID: 22103590, 1301932). Three submitters have cited clinical-significance assessments for this variant to ClinVar after 2014. All submitters classified the variant as pathogenic/likely pathogenic. Based on the evidence outlined above, the variant was classified as pathogenic. - |
F8-related disorder Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | Oct 28, 2023 | The F8 c.1660A>G variant is predicted to result in the amino acid substitution p.Ser554Gly. This variant, also referred to as p.Ser535Gly using legacy nomenclature, has been reported in individuals with mild to moderate hemophilia A (Diamond et al. 1992. PubMed ID: 1301932; Antonarakis et al. 1995. PubMed ID: 7728145; Liu et al. 2002. PubMed ID: 11858487; F8 database: https://www.factorviii-db.org/index.php). Different missense variants in the same codon (p.Ser554Arg; p.Ser554Cys; p.Ser554Asn) have been reported in individuals with hemophilia A (Feng et al. 2021. PubMed ID: 33245802; Bogdanova et al. 2001. PubMed ID: 11748850; Rydz et al. 2013. PubMed ID: 23913812; F8 database: https://www.factorviii-db.org/index.php). This variant is reported in 0.0036% of alleles in individuals of Latino descent in gnomAD (http://gnomad.broadinstitute.org/variant/X-154185324-T-C). This variant is interpreted as likely pathogenic. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at